Increasing a Robust Antigen-Specific Cytotoxic T Lymphocyte Response by FMDV DNA Vaccination with IL-9 Expressing Construct

Increasing a Robust Antigen-Specific Cytotoxic T Lymphocyte Response by FMDV DNA Vaccination with IL-9 Expressing Construct

Various chemokines and cytokines as adjuvants can be used to improve efficacy of DNA vaccination. In this study, we sought to investigate if a DNA construct expressing IL-9 (designed as proV-IL9) as a molecular adjuvant enhance antigen specific immune responses elicited by the pcD-VP1 DNA vaccinatio...

Full description

Bibliographic Details
Main Authors:	Qiang Zou, Bing Wu, Xiaodan He, Yizhi Zhang, Youmin Kang, Jin Jin, Hanqian Xu, Hu Liu, Bin Wang
Format:	Article
Language:	English
Published:	Hindawi Limited 2010-01-01
Series:	Journal of Biomedicine and Biotechnology
Online Access:	http://dx.doi.org/10.1155/2010/562356

Similar Items

Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge.
by: Gang Wang, et al.
Published: (2011-01-01)

In vitro assembly and antigenic analysis of the recombinant structural precursor polypeptide of FMDV
by: Goodwin, Stewart James
Published: (2007)

Recognition of antigen and superantigen by cytotoxic T lymphocytes
by: Bowness, Paul
Published: (1993)

Presentation of peptide antigens to cytotoxic T lymphocytes
by: Elvin, John G.
Published: (1992)

Cytotoxic effects of antigen-transformed lymphocytes
by: Butterworth, A. E.
Published: (1973)

Cytotoxic T Lymphocytes and Vaccine Development
by: Zhengguo Xiao, et al.
Published: (2010-01-01)

Effect of Cytotoxic T-Lymphocyte Antigen-4 on the Efficacy of the Fatty Acid-Binding Protein Vaccine Against Schistosoma japonicum
by: Chun-lian Tang, et al.
Published: (2019-05-01)

The VPI G-H loop of FMDV : importance for protection and exploitation in marker vaccines
by: Fowler, Veronica Louise
Published: (2008)

Development of a DNA Vaccine against Cytotoxic T-lymphocyte Associated Antigen-4 (CTLA-4)
by: Cheng-Liang Tsai, et al.
Published: (2014)

Cytotoxic T Lymphocytes and Vaccine Development 2013
by: Zhengguo Xiao, et al.
Published: (2013-01-01)

Cytotoxic T Lymphocytes and Vaccine Development 2011
by: Zhengguo Xiao, et al.
Published: (2011-01-01)

Mathematical Quantification of Transmission in Experiments: FMDV Transmission in Pigs Can Be Blocked by Vaccination and Separation
by: Aldo Dekker, et al.
Published: (2020-11-01)

Studies on the structure and function of the FMDV genome
by: Tiley, L.
Published: (1989)

Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma
by: Tosti G, et al.
Published: (2013-10-01)

T Helper 17 Promotes Induction of Antigen-Specific Gut-Mucosal Cytotoxic T Lymphocytes following Adenovirus Vector Vaccination
by: Masahisa Hemmi, et al.
Published: (2017-11-01)

The protective capacity of high payload FMDV A22 IRQ vaccine in sheep against direct-contact challenge with a heterologous, contemporary FMDV A strain from South East Asia.
by: Jacquelyn Horsington, et al.
Published: (2018-01-01)

Expansion of cancer germline antigen–specific cytotoxic T lymphocytes for immunotherapy
by: Deepa Kolaseri Krishnadas, et al.
Published: (2017-07-01)

Regulation of FMDV infection by cellular rab GTPases
by: Johns, Helen Louise
Published: (2007)

Antigenic heterogeneity of capsid protein VP1 in foot-and-mouth disease virus (FMDV) serotype Asia1
by: Alam SM, et al.
Published: (2013-08-01)

Delivery of Exogenous Antigens to Induce Cytotoxic CD8+ T Lymphocyte Responses
by: Julia Kim, et al.
Published: (2010-01-01)

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
by: Verschraegen C
Published: (2012-01-01)

Typing and serological surveillance of FMDV in the African buffaloes in Zambia
by: Tingiya Sikombe, et al.
Published: (2014-04-01)

Selection and characterisation of RNA aptamers to FMDV 3Dpol
by: Ellingham, Mark David
Published: (2006)

Biophysical and biochemical studies of the FMDV and EMCV IRES elements
by: Onuegbu, Anthonia Chinwe
Published: (2013)

The polyclonal antibody response to FMDV in cattle and African buffalo
by: Philp, Rebecca L.
Published: (2017)

IFN-α as an Adjuvant for Adenovirus-Vectored FMDV Subunit Vaccine through Improving the Generation of T Follicular Helper Cells.
by: Chunxia Su, et al.
Published: (2013-01-01)

Influence of pregnancy on the specificity and breadth of antigen recognition by HIV-specific cytotoxic T lymphocytes
by: Lapointe Normand, et al.
Published: (2008-04-01)

The fine specificity of HLA class I-restricted antigen recognition by cytotoxic T lymphocytes
by: Moots, Robert J.
Published: (1992)

Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: Another Therapeutic Side of Capecitabine
by: Afshin Derakhshani, et al.
Published: (2021-05-01)

Molecular epidemiology of FMDV in Isfahan province of Iran (2006-2009)
by: Nabinejad, A., et al.
Published: (2014-05-01)

Design, synthesis and analysis of FMDV 3C-protease inhibitors
by: Rosell, Nuria Roque
Published: (2008)

Lentviral-mediated RNAi to inhibit target gene expression of the porcine integrin αv subunit, the FMDV receptor, and against FMDV infection in PK-15 cells
by: Lin Tong, et al.
Published: (2011-09-01)

Robust expression and secretion of Xylanase1 in Chlamydomonas reinhardtii by fusion to a selection gene and processing with the FMDV 2A peptide.
by: Beth A Rasala, et al.
Published: (2012-01-01)

Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI
by: Margison Geoffrey P, et al.
Published: (2006-03-01)

DDX21, a Host Restriction Factor of FMDV IRES-Dependent Translation and Replication
by: Sahibzada Waheed Abdullah, et al.
Published: (2021-09-01)

Association of Porcine Swine Leukocyte Antigen (SLA) Haplotypes with B- and T-Cell Immune Response to Foot-and-Mouth Disease Virus (FMDV) Peptides
by: Patricia de León, et al.
Published: (2020-09-01)

Expression of FMDV (Foot and Mouth Disease Virus) structural protein P1 in transgenic potato and study of the cytotoxic activities of its crude extracts.
by: Jui-Shan Yi, et al.
Published: (2008)

The potential effects of Cytotoxic T lymphocyte antigen 4 -Ig on human B cell response
by: Chih-Tai Ssu, et al.
Published: (2017)

P16-23. Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance
by: McMichael AJ, et al.
Published: (2009-10-01)

Progress in Research on Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) and Bladder Cancer
by: Wei-Ming Fang, et al.
Published: (2019-01-01)

Cannot write session to /tmp/vufind_sessions/sess_h6eb32brk15hr8tnufq2iov5us